Trump signs order to accelerate research and experimental access to psychedelics in the US

Text mentions ibogaine, currently classified in the country as a substance with no accepted medical use and with a high potential for abuse. The measure does not automatically release treatments, but orders prioritizing analysis, expanding studies and opening a regulatory path for eligible patients.